Data gathered: October 18
AI Stock Analysis - Eli Lilly and Company (LLY)
Analysis generated October 9, 2025. Powered by Chat GPT.
Eli Lilly and Company (NYSE: LLY) is a global leader in pharmaceuticals, dedicated to creating high-quality medicines that address significant medical needs. The company engages in the discovery, development, manufacturing, and commercialization of products in two business segments: Human Pharmaceutical Products and Animal Health. Established in 1876 and headquartered in Indianapolis, Indiana, Eli Lilly has a well-established portfolio, including key brands such as Humalog, Trulicity, and Alimta.
Stock Alerts - Eli Lilly and Company (LLY)
 |
Eli Lilly and Company | October 17 Reddit mentions are up by 232% in the last 24h. |
|
Eli Lilly and Company | October 15 Insider Alert: LILLY ENDOWMENT INC is continuing selling shares |
|
Eli Lilly and Company | October 10 Val Hoyle (member of U.S. congress) is selling shares |
|
Eli Lilly and Company | October 7 Insider Alert: LILLY ENDOWMENT INC is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Eli Lilly and Company
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 892 | Sign up | Sign up | Sign up |
| Sentiment | 79 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,875,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 451 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 10,600 | Sign up | Sign up | Sign up |
| Facebook Followers | 254,499 | Sign up | Sign up | Sign up |
| Instagram Followers | 52,335 | Sign up | Sign up | Sign up |
| Reddit Mentions | 27 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 260 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 29,920 | Sign up | Sign up | Sign up |
| Twitter Followers | 143,928 | Sign up | Sign up | Sign up |
| Twitter Mentions | 259 | Sign up | Sign up | Sign up |
| X Mentions | 198 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 83 | Sign up | Sign up | Sign up |
| Linkedin Employees | 52,241 | Sign up | Sign up | Sign up |
About Eli Lilly and Company
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
| Price | $802.83 |
| Target Price | Sign up |
| Volume | 3,940,000 |
| Market Cap | $720B |
| Year Range | $624.31 - $925.9 |
| Dividend Yield | 0.68% |
| PE Ratio | 52.37 |
| Analyst Rating | 89% buy |
| Earnings Date | October 30 '25 |
| Industry | Drug Manufacturers |
In the news
Guggenheim Reiterates Eli Lilly and (LLY) Buy RecommendationOctober 16 - Fintel |
|
 |
Erste Group Upgrades Eli Lilly (LLY) to Buy Following Strong First-Half ResultsOctober 15 - Yahoo |
|
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should KnowOctober 15 - Yahoo |
 |
How LLY Stock Delivered $47 Billion To ShareholdersOctober 15 - Forbes |
|
1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy TodayOctober 14 - Yahoo |
|
Should Omvoh’s Clinical Results and Innovation Drive a Rethink of Eli Lilly’s (LLY) Specialty Focus?October 12 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 15.6B | 2.45B | 13.1B | 5.66B | 7.5B | 6.310 |
| Q1 '25 | 12.7B | 2.22B | 10.5B | 2.76B | 4.16B | 3.340 |
| Q4 '24 | 13.5B | 2.4B | 11.1B | 4.41B | 5.75B | 5.320 |
| Q3 '24 | 11.4B | 2.17B | 9.27B | 970M | 2.25B | 1.180 |
| Q2 '24 | 11.3B | 2.17B | 9.13B | 2.97B | 4.12B | 3.920 |
Insider Transactions View All
| LILLY ENDOWMENT INC filed to sell 94,536,510 shares at $862.3. October 14 '25 |
| LILLY ENDOWMENT INC filed to sell 94,533,320 shares at $863.4. October 14 '25 |
| LILLY ENDOWMENT INC filed to sell 94,536,978 shares at $857.3. October 10 '25 |
| LILLY ENDOWMENT INC filed to sell 94,546,580 shares at $850.1. October 10 '25 |
| LILLY ENDOWMENT INC filed to sell 94,546,980 shares at $848.6. October 10 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$193.22 0% | 66 |
 |
PfizerPFE |
$24.51 0% | 60 |
 |
AstrazenecaAZN |
$84.69 0% | 59 |
 |
AbbVieABBV |
$229.57 0% | 63 |
 |
TherapeuticsMDTXMD |
$1.25 0% | 41 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Val Hoyle |
Oct 10, 25 | Sell | $1K - $15K |
| Valerie Hoyle |
Sep 12, 25 | Buy | $1K - $15K |
| Julie Johnson |
Sep 12, 25 | Sell | $1K - $15K |
Read more about Eli Lilly and Company (LLY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Eli Lilly and Company?
The Market Cap of Eli Lilly and Company is $720B.
What is Eli Lilly and Company's PE Ratio?
As of today, Eli Lilly and Company's PE (Price to Earnings) ratio is 52.37.
When does Eli Lilly and Company report earnings?
Eli Lilly and Company will report its next earnings on October 30 '25.
What is the current stock price of Eli Lilly and Company?
Currently, the price of one share of Eli Lilly and Company stock is $802.83.
How can I analyze the LLY stock price chart for investment decisions?
The LLY stock price chart above provides a comprehensive visual representation of Eli Lilly and Company's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eli Lilly and Company shares. Our platform offers an up-to-date LLY stock price chart, along with technical data analysis and alternative data insights.
Does LLY offer dividends to its shareholders?
Yes, Eli Lilly and Company (LLY) offers dividends to its shareholders, with a dividend yield of 0.68%. This dividend yield represents Eli Lilly and Company's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Eli Lilly and Company in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Eli Lilly and Company?
Some of the similar stocks of Eli Lilly and Company are Johnson & Johnson, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.
.
